All News

Discover how the SkinTracker app enhances AD management through remote assessments, offering convenience and accuracy comparable to in-person visits.

Questions remain related to which patients with diffuse large B-cell lymphoma (DLBCL) benefit most from radiotherapy and at what dose.

The FDA has approved belantamab mafodotin for third-line or later multiple myeloma based on DREAMM-7 trial data.

Removing out-of-pocket costs for follow-up colonoscopy led to an immediate and sustained increase in utilization.

AI-powered mammography is enhancing breast cancer screening and early detection through cutting-edge radiology insights.

Heart rate variability (HRV) biofeedback may be a potential intervention for patients with coronary artery disease.

Which hormonal contraceptives are still safe, when should women stop using them, and what other benefits do they offer during the menopause transition?

Using masks that tie up in the back and being aware of environmental factors can help protect eyes during Halloween trick-or-treating.

Explore the critical implications of proposed Medicaid cuts on health care access, costs, and community well-being in the US.

A novel combination therapy enhances the effectiveness of proteasome inhibitors against acute myeloid leukemia (AML), improving survival rates in preclinical models.

Patients with fatty liver disease are significantly more likely to develop kidney stones, a national study found.

Dana-Farber researchers have uncovered mutation pathways driving aggressive disease transformation.

Venetoclax plus bortezomib and dexamethasone improved PFS in relapsed/refractory multiple myeloma, especially in patients with BCL2high disease.

A targeted therapy combination achieved complete remission in a CAR-positive PTCL patient post-CAR T-cell therapy for multiple myeloma.

LAG-3 expression appears to be significantly elevated in patients with small cell lung cancer (SCLC).

Health care workers face significant financial hardships, including food insecurity and housing instability, impacting retention and patient care quality.

COVID-19–related work absences remain elevated post pandemic, especially in high-exposure jobs, highlighting lasting labor market impacts.

Meta-analyses presented at the CHEST 2025 Annual Meeting find that combinations that include amivantamab and nivolumab improved overall and progression-free survival in non–small cell lung cancer (NSCLC).

The efficacy of GLP-1 inhibitors in weight loss has introduced them as a means of also addressing obstructive sleep apnea in sleep medicine.

Experts also explained how hormone therapy can benefit women managing chronic conditions such as diabetes and hypertension on top of their menopause.

A session held during the CHEST 2025 Annual Meeting focused on the North American guidelines for treating bronchiectasis.

Melanie T. Turk, PhD, RN, discusses her study on nationwide challenges program suppliers face in implementing the Medicare Diabetes Prevention Program (MDPP).

Susan Escudier, MD, discusses the practical implications of financial barriers for patients with cancer accessing oncology care.

Physician burnout rates have decreased since the pandemic, but the likelihood of Medicare exits threatens access to underserved populations.

A study reveals disparities by sex, socioeconomic status, and location for colorectal cancer screenings.

Telehealth medication abortion service requests double after the Supreme Court's Dobbs ruling, as patients seek accessible and cost-beneficial care.

Researchers will present new findings on how menopause affects cardiovascular, brain, metabolic, and digestive health.

Higher body size and metabolic factors are linked to worse psoriasis and lower biologic treatment success.